<body><a name="drugname"></a><table class="topbox" width="100%">
<tr>
<td><span class="topboxgenname">DORNASE ALFA</span><br/>(dor'naze)<br/><span class="topboxtradename">Pulmozyme<br/></span><b>Classifications:</b> <span class="classification">antitussive, expectorant, and mucolytic agents</span>; <span class="classification">mucolytic</span><br/><b>Pregnancy Category: </b>B<br/></td>
</tr>
</table>
<h1><a name="avail">Availability</a></h1>
<p>1 mg/mL solution for inhalation</p>
<h1><a name="action">Actions</a></h1>
<p>Dornase is a solution of recombinant human deoxyribonuclease (DNAse), an enzyme that selectively cleaves DNA. In cystic fibrosis
         (CF) patients, viscous, purulent secretions in the airway reduce pulmonary function and lead to exacerbations of infection.
         Purulent pulmonary secretions contain very high concentrations of DNA released by degenerating leukocytes that are present
         in response to infection.
      </p>
<h1><a name="therapef">Therapeutic Effects</a></h1>
<p>Dornase hydrolyzes the DNA in sputum of CF patients and reduces sputum viscosity. Use of dornase significantly reduces number
         of upper respiratory infections acquired by patients with CF.
      </p>
<h1><a name="uses">Uses</a></h1>
<p>In combination with standard therapies to reduce the frequency of respiratory infections in patients with CF and to improve
         pulmonary function.
      </p>
<h1><a name="unlabeleduses">Unlabeled Uses</a></h1>
<p>Chronic bronchitis.</p>
<h1><a name="contrain">Contraindications</a></h1>
<p>Hypersensitivity to dornase.</p>
<h1><a name="precaution">Cautious Use</a></h1>
<p>Pregnancy (category B), lactation, infants 
      </p><h1><a name="rtedsg">Route &amp; Dosage</a></h1>
<table cellpadding="4" cellspacing="0" class="rdbox" width="100%">
<tr>
<td><span class="indicationtitle">Cystic Fibrosis</span><br/><span class="rdage">Adult/</span><span class="rdage">Child:</span> <span class="rdroute">Inhalation</span> &gt;<i>3 mo</i>, 2.5 mg (1 ampule) inhaled once  daily using a recommended nebulizer, may increase to twice daily (do not mix with other agents in nebulizer)<br/></td>
</tr>
</table>
<h1><a name="admintn">Administration</a></h1><span class="adminroutetype">Inhalation</span><br/><ul>
<li>Do not dilute or mix with any other drugs or solutions in the nebulizer.</li>
<li>Use only with nebulizer systems recommended by the drug manufacturer.</li>
<li>Do not shake ampuls; do not use ampuls that have been at room temperature longer than 24 h or have become cloudy or discolored.</li>
<li>Store refrigerated at 2°8° C (36°46° F) in protective foil pouch.</li>
</ul>
<h1><a name="adverse">Adverse Effects (<img src="../images/special/greaterorequal.gif"/>1%)</a></h1><span class="typehead">Respiratory:</span> Hoarseness, sore throat, voice alterations, pharyngitis, laryngitis, cough, rhinitis. <span class="typehead">Other:</span> Conjunctivitis, chest pain, rash. 
      <h1><a name="pharmaks">Pharmacokinetics</a></h1><span class="typehead">Absorption:</span> Minimal systemic absorption. <span class="typehead">Onset:</span> 38 d. <span class="typehead"> Duration:</span> Benefit lasts up to 4 d after discontinuing treatment. 
      <h1><a name="nursing"><span class="implictitle">Nursing Implications</span></a></h1>
<p><span class="adeffecttitle">Assessment &amp; Drug Effects</span></p>
<ul>
<li>Monitor for improvement in dyspnea and sputum clearance.</li>
<li>Monitor for S&amp;S of hypersensitivity (see Appendix F). Patients with a history of hypersensitivity to bovine pancreatic dornase
            are at high risk.
         </li>
<li>Monitor for adverse effects; rarely, dosage adjustments may be required.</li>
</ul>
<p><span class="eductitle">Patient &amp; Family Education</span></p>
<ul>
<li>Report rash, hives, itching, or other S&amp;S of hypersensitivity to physician immediately.</li>
<li>Know potential adverse effects and report those that are bothersome or do not disappear.</li>
<li>Take a missed dose as soon as possible; if it is almost time for the next dose, skip the missed dose.</li>
<li>Do not breast feed while taking this drug without consulting physician.</li>
</ul>
<hr/>
<p><span class="footer">Common adverse effects in <i>italic</i>, life-threatening effects <u>underlined</u>; generic names in <b>bold</b>; classifications in <small>SMALL CAPS</small>; <img border="0" src="../images/maple.gif"/> Canadian drug name; <img border="0" src="../images/pr.gif"/> Prototype drug</span></p>
</body>